Figure 1.
Proposed framework to measure drivers of disparities. CAR-T, chimeric antigen receptor T-cell therapy; MIBG, iodine meta- iodobenzylguanidine therapy; SNP, single nucleotide polymorphism.

Proposed framework to measure drivers of disparities. CAR-T, chimeric antigen receptor T-cell therapy; MIBG, iodine meta- iodobenzylguanidine therapy; SNP, single nucleotide polymorphism.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal